Incretin-Pathway Peptides
CagriSema
A two-component blend of cagrilintide and semaglutide, sealed as a lyophilized vial for comparative signaling research.
5mg total · 10mg total · 20mg total
View Details
Incretin-Pathway Peptides
An acylated amylin analogue supplied as a sealed lyophilized vial for receptor-pharmacology and stability research.
Research use only
Cagrilintide is an acylated analogue of amylin, modified for extended activity relative to the native peptide. It sits in the incretin-pathway section of this catalog alongside other long-acting peptide analogues.
Research applications for material of this kind include amylin-receptor pharmacology studies, peptide stability assessment, structural analysis, and use as a reference standard in analytical workflows. The molecular weight shown on this page refers to the acetate form; salt form and lot-specific detail are set out in batch documentation.
Vials are sealed after freeze-drying and available at the nominal masses listed under available sizes, from 5mg through 20mg.
| Purity | ≥99% by HPLC |
|---|---|
| CAS number | 1415456-99-3 |
| Molecular weight | 4409 g/mol (acetate) |
| Molecular formula | C194H312N54O59S2 |
| Material class | Modified peptide analogue |
| Appearance | White to off-white lyophilized powder |
| Available vial sizes | 5mg · 10mg · 20mg |
| Documentation | Batch documentation confirmed on request |